CureVac's amended patent survives BioNTech's challenge as EPO upholds validity. A German court will decide on infringement in ...

European Patent Office largely dismisses opposition filed by BioNTech SE in April 2023 challenging validity of EP 3 708 668 ...

The European Patent Office declared a patent owned by CureVac , valid, after a challenge from drugmaker BioNTech , the company said on Thursday.

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that ...

European Patent Office (EPO) received nearly 200,000 patent applications last year, with 6.6% coming from the Republic of KoreaStrongest growth globally came from electrical machinery, apparatus ...

European Patent Office (EPO) received nearly 200,000 patent applications last year, with 6.6% coming from the Republic of Korea Strongest growth globally ...

European Patent Office received nearly 200 000 patent applications last year, with Japanese companies and inventors filing 10.6% of the total Electrical machinery/energy, transport and computers ...

March 27 (Reuters) - The European Patent Office declared a patent owned by CureVac (5CV.DE), opens new tab, valid, after a challenge from drugmaker BioNTech (22UAy.DE), opens new tab, the company ...

According to the latest Patent Index 2024, published today by the European Patent Office (EPO), Japan ranked third worldwide, following the United States and Germany.

On Tuesday, the European Patent Office (EPO) published the Patent Index 2024, the latest edition of the EU patent agency’s ...

The European Patent Office’s (EPO) Patent Index 2024, published this week, reveals that nearly 200,000 patent applications were filed last year, proving that Europe’s inventors are pushing ...